These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 35130317)

  • 1. Associations of lymphocyte subpopulations with clinical phenotypes and long-term outcomes in juvenile-onset systemic lupus erythematosus.
    Lerkvaleekul B; Apiwattanakul N; Tangnararatchakit K; Jirapattananon N; Srisala S; Vilaiyuk S
    PLoS One; 2022; 17(2):e0263536. PubMed ID: 35130317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do classic blood biomarkers of JSLE identify active lupus nephritis? Evidence from the UK JSLE Cohort Study.
    Smith EMD; Jorgensen AL; Beresford MW;
    Lupus; 2017 Oct; 26(11):1212-1217. PubMed ID: 28385126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased Fas and Bcl-2 expression on peripheral blood T and B lymphocytes from juvenile-onset systemic lupus erythematosus, but not from juvenile rheumatoid arthritis and juvenile dermatomyositis.
    Liphaus BL; Kiss MH; Carrasco S; Goldenstein-Schainberg C
    Clin Dev Immunol; 2006; 13(2-4):283-7. PubMed ID: 17162369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and laboratory characteristics in juvenile-onset systemic lupus erythematosus across age groups.
    Massias JS; Smith EMD; Al-Abadi E; Armon K; Bailey K; Ciurtin C; Davidson J; Gardner-Medwin J; Haslam K; Hawley DP; Leahy A; Leone V; McErlane F; Mewar D; Modgil G; Moots R; Pilkington C; Ramanan AV; Rangaraj S; Riley P; Sridhar A; Wilkinson N; Beresford MW; Hedrich CM
    Lupus; 2020 Apr; 29(5):474-481. PubMed ID: 32233733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential analysis of serum and urine S100 proteins in juvenile-onset systemic lupus erythematosus (jSLE).
    Donohue SJ; Midgley A; Davies JC; Wright RD; Bruce I; Beresford MW; Hedrich CM; ;
    Clin Immunol; 2020 May; 214():108375. PubMed ID: 32135275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased apolipoprotein-B:A1 ratio predicts cardiometabolic risk in patients with juvenile onset SLE.
    Robinson GA; Waddington KE; Coelewij L; Peng J; Naja M; Wincup C; Radziszewska A; Peckham H; Isenberg DA; Ioannou Y; Ciurtin C; Pineda-Torra I; Jury EC
    EBioMedicine; 2021 Mar; 65():103243. PubMed ID: 33640328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for subsequent lupus nephritis in patients with juvenile-onset systemic lupus erythematosus: a retrospective cohort study.
    Hsu TC; Yang YH; Wang LC; Lee JH; Yu HH; Lin YT; Hu YC; Chiang BL
    Pediatr Rheumatol Online J; 2023 Mar; 21(1):28. PubMed ID: 36964531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary interleukin 22 binding protein as a marker of lupus nephritis in Egyptian children with juvenile systemic lupus erythematosus.
    Badr AMM; Farag Y; Abdelshafy M; Riad NM
    Clin Rheumatol; 2018 Feb; 37(2):451-458. PubMed ID: 28887660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and laboratory phenotypes in juvenile-onset Systemic Lupus Erythematosus across ethnicities in the UK.
    Massias JS; Smith EM; Al-Abadi E; Armon K; Bailey K; Ciurtin C; Davidson J; Gardner-Medwin J; Haslam K; Hawley DP; Leahy A; Leone V; McErlane F; Mewar D; Modgil G; Moots R; Pilkington C; Ramanan AV; Rangaraj S; Riley P; Sridhar A; Wilkinson N; Beresford MW; Hedrich CM
    Lupus; 2021 Apr; 30(4):597-607. PubMed ID: 33413005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical predictors of proteinuric remission following an LN flare - evidence from the UK JSLE cohort study.
    Smith EMD; Yin P; Jorgensen AL; Beresford MW;
    Pediatr Rheumatol Online J; 2018 Feb; 16(1):14. PubMed ID: 29467038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced expressions of apoptosis-related proteins TRAIL, Bcl-2, and TNFR1 in NK cells of juvenile-onset systemic lupus erythematosus patients: relations with disease activity, nephritis, and neuropsychiatric involvement.
    Liphaus BL; Silva SC; Palmeira P; Silva CA; Goldenstein-Schainberg C; Carneiro-Sampaio M
    Front Immunol; 2024; 15():1327255. PubMed ID: 38562920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Disease Characteristics, Organ Damage, and Survival in Patients with Juvenile-onset and Adult-onset Systemic Lupus Erythematosus in a Combined Cohort from 2 Tertiary Centers in Turkey.
    Artim-Esen B; Şahin S; Çene E; Şahinkaya Y; Barut K; Adrovic A; Özlük Y; Kılıçaslan I; Omma A; Gül A; Öcal L; Kasapçopur Ö; İnanç M
    J Rheumatol; 2017 May; 44(5):619-625. PubMed ID: 28298568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell activation, PD-1 expression and in vitro cytokine production in patients with juvenile systemic lupus erythematosus.
    Yamada J; Peracchi OA; Terreri MT; de Moraes-Pinto MI
    Lupus; 2022 Sep; 31(10):1237-1244. PubMed ID: 35849633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous changes in serum HMGB1 and IFN-α levels and in LAIR-1 expression on plasmatoid dendritic cells of patients with juvenile SLE. New therapeutic options?
    Kanakoudi-Tsakalidou F; Farmaki E; Tzimouli V; Taparkou A; Paterakis G; Trachana M; Pratsidou-Gertsi P; Nalbanti P; Papachristou F
    Lupus; 2014 Mar; 23(3):305-12. PubMed ID: 24399813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical predictors of active LN development in children - evidence from the UK JSLE Cohort Study.
    Smith EMD; Yin P; Jorgensen AL; Beresford MW
    Lupus; 2018 Nov; 27(13):2020-2028. PubMed ID: 30246602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up regulation of serum tumor necrosis factor-related apoptosis inducing ligand in juvenile-onset systemic lupus erythematosus: relations with disease activity, antibodies to double -stranded DNA, nephritis and neutropenia.
    Ezzat MH; El-Gammasy TM; Shaheen KY; El-Mezdawi RA; Youssef MS
    Int J Rheum Dis; 2013 Jun; 16(3):310-8. PubMed ID: 23981753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Fas and Bcl-2 expression on peripheral mononuclear cells from patients with active juvenile-onset systemic lupus erythematosus.
    Liphaus BL; Kiss MH; Carrasco S; Goldenstein-Schainberg C
    J Rheumatol; 2007 Jul; 34(7):1580-4. PubMed ID: 17516614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocyte apoptosis and its association with the inflammatory markers and disease severity in juvenile-onset systemic lupus erythematosus patients.
    Eissa E; Kandil R; Dorgham D; Ghorab R; Kholoussi N
    Pediatr Rheumatol Online J; 2024 Jan; 22(1):20. PubMed ID: 38243322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges of achieving clinical remission in a national cohort of juvenile-onset systemic lupus erythematosus patients.
    Abdelrahman N; Beresford MW; Leone V;
    Lupus; 2019 Apr; 28(5):667-674. PubMed ID: 30943853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pro-inflammatory potential of T cells in juvenile-onset systemic lupus erythematosus.
    Ballantine LE; Ong J; Midgley A; Watson L; Flanagan BF; Beresford MW
    Pediatr Rheumatol Online J; 2014 Jan; 12():4. PubMed ID: 24433387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.